Literature DB >> 19524402

The relationship of left atrial volume and left atrial pressure in patients with hypertrophic cardiomyopathy: an echocardiographic and cardiac catheterization study.

Jeffrey B Geske1, Paul Sorajja, Rick A Nishimura, Steve R Ommen.   

Abstract

BACKGROUND: Left atrial enlargement is a marker of diastolic dysfunction, which is present in most patients with hypertrophic cardiomyopathy (HCM). It is unclear as to whether left atrial volume is a reliable measure of ventricular filling pressures in these patients.
METHODS: Left atrial volume index (LAVI) was measured in 100 symptomatic patients with HCM using transthoracic echocardiography, followed by cardiac catheterization with transseptal measurement of left atrial pressure (LAP) and end-diastolic pressure within 48 hours.
RESULTS: LAVI was only modestly related to mean LAP (r=0.24, P=.02), and there was no significant relation to end-diastolic pressure (r=0.11, P=.28). The specificity of increased LAVI (>28 cm3/m2) for elevated LAP (>15 mm Hg) was poor (16%). However, all patients with normal LAVI had normal LAP.
CONCLUSIONS: Although left atrial size may reflect chronic changes due to diastolic dysfunction in HCM, the relation of increased LAVI to ventricular filling pressures is modest. Nonetheless, a normal LAVI suggests normal ventricular filling pressures in patients with HCM.

Entities:  

Mesh:

Year:  2009        PMID: 19524402     DOI: 10.1016/j.echo.2009.05.003

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  11 in total

1.  Normal left-atrial structure and function despite concentric left-ventricular remodelling in a cohort of patients with Anderson-Fabry disease.

Authors:  Brendan N Putko; Haran Yogasundaram; Kelvin Chow; Joseph Pagano; Aneal Khan; D Ian Paterson; Richard B Thompson; Gavin Y Oudit
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03-06       Impact factor: 6.875

Review 2.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

3.  Left atrial volume and function measured by cardiac magnetic resonance imaging as predictors of shocks and mortality in patients with implantable cardioverter-defibrillators.

Authors:  Inna Y Gong; Payam Yazdan-Ashoori; Laura Jimenez-Juan; Nigel S Tan; Paul Angaran; Binita Riya Chacko; Saif Al-Mousawy; Sheldon M Singh; Tamar Shalmon; Luciano Folador; Iqwal Mangat; Djeven P Deva; Andrew T Yan
Journal:  Int J Cardiovasc Imaging       Date:  2021-03-01       Impact factor: 2.357

Review 4.  Importance of the Left Atrium: More Than a Bystander?

Authors:  Kalie Y Kebed; Karima Addetia; Roberto M Lang
Journal:  Heart Fail Clin       Date:  2019-02-02       Impact factor: 3.179

5.  Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease.

Authors:  Fadia Mayyas; Mark Niebauer; Andrew Zurick; John Barnard; A Marc Gillinov; Mina K Chung; David R Van Wagoner
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-05-21

6.  EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  J Arrhythm       Date:  2016-07-11

Review 7.  Risk factors of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Ying Hong; Wilber W Su; Xiaoping Li
Journal:  Curr Opin Cardiol       Date:  2022-01-01       Impact factor: 2.108

8.  Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population.

Authors:  Konstantinos C Siontis; Jeffrey B Geske; Kevin Ong; Rick A Nishimura; Steve R Ommen; Bernard J Gersh
Journal:  J Am Heart Assoc       Date:  2014-06-25       Impact factor: 5.501

9.  Orthogonal P-wave morphology is affected by intra-atrial pressures.

Authors:  Richard Petersson; J Gustav Smith; David A Larsson; Öyvind Reitan; Jonas Carlson; Pyotr Platonov; Fredrik Holmqvist
Journal:  BMC Cardiovasc Disord       Date:  2017-12-06       Impact factor: 2.298

10.  Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.

Authors:  Dai-Yin Lu; Iraklis Pozios; Bereketeab Haileselassie; Ioannis Ventoulis; Hongyun Liu; Lars L Sorensen; Marco Canepa; Susan Phillip; M Roselle Abraham; Theodore P Abraham
Journal:  J Am Heart Assoc       Date:  2018-02-25       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.